The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Official Title: An Open-Label Phase 2 Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
Study ID: NCT00116389
Brief Summary: The purpose of this study is to assess the 6-month survival rate and safety of talabostat and gemcitabine in patients with stage IV adenocarcinoma of the pancreas.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Northwest Alabama Cancer Center, PC, Florence, Alabama, United States
Northwest Alabama Cancer Center, PC, Muscle Shoals, Alabama, United States
Oncology Associates, PC, Hartford, Connecticut, United States
Palm Beach Institute of Hematology and Oncology, Boynton Beach, Florida, United States
Cancer Center of Florida, Ocoee, Florida, United States
Hematology Oncology Associates of Central Brevard, Rockledge, Florida, United States
Gulfcoast Oncology Associates, St. Petersburg, Florida, United States
Yagnesh V. Oza, MD, Mt. Vernon, Illinois, United States
Indiana Oncology Hematology Consultants, Indianapolis, Indiana, United States
Cancer Care Center, Inc., New Albany, Indiana, United States
Medical Oncology LLC, Baton Rouge, Louisiana, United States
Huron Medical Center, Port Huron, Michigan, United States
Billings Clinic, Billings, Montana, United States
Monmouth Medical Center, Long Branch, New Jersey, United States
New York Oncology Hematology/Albany Regional Cancer Center, Albany, New York, United States
Hematology-Oncology Associates of Rockland, New City, New York, United States
Dayton Oncology and Hematology, Kettering, Ohio, United States
Lawrence M. Stallings, MD, Wooster, Ohio, United States
Trilogy Cancer Center, Wooster, Ohio, United States
Providence Portland Medical Center, Portland, Oregon, United States
Oregon Clinic, The, Portland, Oregon, United States
Cancer Center of the Carolinas, Greenville, South Carolina, United States
Mary Crowley Medical Research Center, Dallas, Texas, United States
Texas Oncology, PA, Presbyterian, Dallas, Texas, United States
Baylor College of Medicine, Houston, Texas, United States
Elkins Pancreas Center, Houston, Texas, United States
Saint Luke's Episcopal Hospital, Houston, Texas, United States
Cancer Care Northwest, Spokane, Washington, United States